A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(8 sites)

South Korea

National Cancer Center, Goyang-si, Gyeonggi-do

Ajou University Medical Center, Suwon, Gyeonggi-do

Asan Medical Center, Seoul, Seoul

Inje University Haeundae Paik Hospital, Busan

Chungnam National University Hospital, Daejeon

Seoul National University Hospital, Seoul

Severance Hospital, Seoul

Samsung Medical Center, Seoul